Information  X 
Enter a valid email address

Vodafone Group Plc (VOD)

  Print      Mail a friend       Annual reports

Friday 31 August, 2018

Vodafone Group Plc

Publication of a Prospectus

RNS Number : 4639Z
Vodafone Group Plc
31 August 2018
 

RNS PUBLICATION FORM

 

Publication of Prospectus

 

The following prospectus has been approved with the UK Listing Authority and is available for viewing:

 

Prospectus dated 31 August 2018 (the "Prospectus") relating to the €30,000,000,000 Euro Medium Term Note Programme of Vodafone Group Plc (the "Issuer").

 

To view the full document, please paste the following URL into the address bar of your browser.

 

Prospectus

 

http://www.rns-pdf.londonstockexchange.com/rns/4639Z_1-2018-8-31.pdf

 

This Prospectus is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact

 

Rosemary Martin
Group General Counsel and Company Secretary

Tel: +44 (0)1635 33251

 

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement. 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PDIZFLFXVVFZBBE

a d v e r t i s e m e n t